Location History:
- San Diego, CA (US) (2018 - 2020)
- Toronto, CA (2021 - 2023)
Company Filing History:
Years Active: 2018-2023
Title: Afton Hiscox: Innovator in GluN2B Receptor Modulation
Introduction
Afton Hiscox is a notable inventor based in San Diego, CA, who has made significant contributions to the field of pharmaceutical sciences. With a total of six patents to his name, Hiscox has focused on developing compounds that target the GluN2B receptor, which plays a crucial role in various neurological conditions.
Latest Patents
Hiscox's latest patents include "Substituted pyrazolo-pyridine amides and their use as GluN2B receptor modulators" and "Substituted heteroaromatic pyrazolo-pyridines and their use as GLUN2B receptor modulators." These innovative compounds are designed to modulate GluN2B receptor activity and can be utilized in pharmaceutical compositions aimed at treating various disease states, disorders, and conditions associated with this receptor.
Career Highlights
Afton Hiscox is currently employed at Janssen Pharmaceutica NV, where he continues to advance his research and development efforts. His work is pivotal in the ongoing exploration of therapeutic options for conditions mediated by GluN2B receptor activity.
Collaborations
Hiscox collaborates with esteemed colleagues, including Curt A. Dvorak and Christine Fang Gelin, who contribute to the innovative research environment at Janssen Pharmaceutica NV.
Conclusion
Afton Hiscox stands out as a key figure in the field of pharmaceutical innovation, particularly in the modulation of GluN2B receptors. His contributions through patents and collaborative efforts are paving the way for new therapeutic approaches in treating neurological disorders.